Chanos says he's still short Valeant (VRX), started in low $100s - CNBC
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Short-seller Jim Chanos says he's still short Valeant Pharma (NYSE: VRX) and started in the low $100s, according to commentary on CNBC.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jim Chanos Negative Again on Valeant Pharma (VRX) in CNBC Interview
- lululemon athletica (LULU) October weekly calls expiring Friday active
- Valeant Pharma (VRX) Said 'Very Close' on One or More Asset Sales
Create E-mail Alert Related CategoriesShort Sales, Trader Talk
Related EntitiesJim Chanos
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!